NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. MSFT

Go back to NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
(NASDAQ: NXTC) Delayed: 1.75 -0.27 (13.37%)
Previous Close $2.02    52 Week High $ 
Open $2.05    52 Week Low $ 
Day High $2.11    P/E N/A 
Day Low $1.72    EPS $ 
Volume 167,164